Cited by 135Fibromyalgia and Chronic Fatigue Syndrome ResearchImmune Cell Function and InteractionLong-Term Effects of COVID-19

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis

Open access
Brenu, Ekua W, van Driel, Mieke L, Staines, Donald R, Ashton, Kevin J, Hardcastle, Sharni L, Keane, James, Tajouri, Lotti, Peterson, Daniel +2 more·2012·Journal of Translational Medicine

Abstract

BACKGROUND: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is an etiologically unexplained disorder characterised by irregularities in various aspects of the immunological function. Presently, it is unknown whether these immunological changes remain consistent over time. This study investigates Natural Killer (NK) cell cytotoxic activity, NK cell subsets (CD56brightCD16- and CD56dimCD16+) and cytokines, over the course of a12 month period in patients with CFS/ME. METHODS: The participants in the study comprised 65 (47.2 ± 11.5 years) CFS/ME participants and 21 (45.2 ± 9.3 years) non-fatigued controls. Flow cytometry protocols were used to assess NK subsets and NK cytotoxic activity at various time points that included baseline (T1), 6 (T2) and 12 months (T3). Cytokine secretions were measured following mitogenic stimulation of peripheral blood mononuclear cells. RESULTS: NK cytotoxic activity was significantly decreased in the CFS/ME patients at T1, T2 and T3 compared to the non-fatigued group. Additionally, in comparison to the non-fatigued controls, the CFS/ME group had significantly lower numbers of CD56brightCD16- NK cells at both T1 and T2. Interestingly, following mitogenic stimulation, cytokine secretion revealed significant increases in IL-10, IFN-γ and TNF-α at T1 in the CFS/ME group. A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls. Overall cytotoxic activity was significantly decreased at T3 compared to T1 and T2. CD56brightCD16- NK cells were much lower at T2 compared to T1 and T3. IL-10 and IL-17A secretion was elevated at T2 in comparison to T1 and T3. CONCLUSION: These results confirm decreases in immune function in CFS/ME patients, suggesting an increased susceptibility to viral and other infections. Furthermore, NK cytotoxic activity may be a suitable biomarker for diagnosing CFS/ME as it was consistently decreased during the course of the 12 months study.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1479-5876-10-88

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Stress acts on the HPG axis through norepinephrine release into the ovaries, and also inhibits the release of GnRH, luteinizing hormone, estrogen, and progesterone.

    “Stress also acts on the HPG axis through norepinephrine release into the ovaries, and also inhibits the release of GnRH, luteinizing hormone, estrogen, and progesterone37.”

    From Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically-relevant Phenotyping of Women with Chronic Fatigue Syndrome (2019) · cites this paper as [37]

    The Discussion addresses NK-cell activity and cytokine secretion in CFS/ME, not stress effects on the HPG axis. Searches for norepinephrine release into the ovaries and for stress-related reproductive hormones found no passage addressing GnRH, luteinizing hormone, estrogen, or progesterone. The claim cannot be verified from our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Estrogen has been shown to increase corticotropin secretion in both female monkeys and rats.

    “Estrogen for example has been shown to increase corticotropin secretion in both female monkeys and rats37, supporting a feedback loop between the HPG and HPA axes.”

    From Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically-relevant Phenotyping of Women with Chronic Fatigue Syndrome (2019) · cites this paper as [37]

    The Results and Discussion passages in our copy concern NK cells and cytokine changes in CFS/ME; no page numbers are available. Searches for estrogen, corticotropin, female monkeys, rats, and HPG/HPA axes found no passage addressing the attributed finding. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 60 · Cited by 135

Authors
Brenu, E. W., van Driel, M. L., Staines, D. R., Ashton, K. J., Hardcastle, S. L., Keane, J., Tajouri, L., Peterson, D., Ramos, S. B., & Marshall-Gradisnik, S. M.
Affiliations
Bond University (AU)
Corresponding author
Brenu, Ekua W
Venue
Journal of Translational Medicine
Published
2012-05-09
Volume
10
Issue
1
Pages
88-88
ISSN
1479-5876 (ISSN-L)
OpenAlex
W2112732153
Cited by
135
References
60
Citations by year
2026: 4 · 2025: 4 · 2024: 13 · 2023: 10 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 15 · 2018: 13 · 2017: 8 · 2016: 18 · 2015: 17 · 2014: 7 · 2013: 15 · 2012: 1
FWCI
9.11
Type
journal article
Language
en
Open access
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bond University Research Portal (Bond University) (submittedVersion, cc-by)
  • Griffith Research Online (submittedVersion, cc-by)
  • e-publications@bond (Bond University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Judith Jane Mason and Harold Stannett Williams Memorial Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
chronic fatigue syndrome, natural killer cells, NK cell subsets, cytokine production, IL-10, IL-17A, interferon-gamma, TNF-α, interleukin-2, immune dysfunction, biomarkers
MeSH terms
Adult, Female, Flow Cytometry, Humans, Killer Cells, Natural, Longitudinal Studies, Male, Middle Aged, Fatigue Syndrome, Chronic, Antigens, CD, Case-Control Studies, Immunophenotyping, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review